Gritstone Bio Total Revenue

Gritstone Bio (GRTS) currently reports a total revenue of $1.7M as of June 2024. That compares with $8.2M in the prior-year period — down 79.3% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Gritstone Bio's total revenue history and peer comparisons.

Gritstone Bio's total revenue decreased from $8.2M to $1.7M — a 79.3% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gritstone Bio's total revenue of $1.7M is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Gritstone Bio reported $1.7M in total revenue as of June 2024. That compares with $8.2M in the prior-year period — down 79.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $1.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Gritstone Bio, and consider following GRTS for alerts when major investors trade the stock.